PET/CT for atherosclerotic plaque imaging
1Department of Nuclear Medicine, Carmel Medical Center, Haifa, Israel. simona@ben-haim.com
Insights
Assessing vulnerable atherosclerotic plaques is crucial for preventing heart attack and stroke. Fluodeoxyglucose imaging shows promise in evaluating plaque stability, offering an alternative to traditional angiography for vulnerable plaque detection.
Area of Science:
- Cardiovascular Imaging
- Nuclear Medicine
- Vascular Biology
Background:
- Atherosclerosis is a major global cause of death.
- Plaque rupture leading to thrombosis underlies myocardial infarction and stroke.
- Traditional angiography visualizes arterial lumen but not plaque composition.
Purpose of the Study:
- To review the role of fluodeoxyglucose (FDG) imaging in atherosclerosis assessment.
- To compare FDG imaging with other modalities for detecting vulnerable plaques.
Main Methods:
- Literature review of studies on FDG imaging in atherosclerosis.
- Comparison of FDG imaging characteristics with other plaque imaging techniques.
Main Results:
- FDG uptake can indicate plaque inflammation and instability.
- FDG imaging may identify plaques at higher risk of rupture.
- Comparison with modalities like MRI and PET.
Conclusions:
- FDG imaging is a potential tool for assessing vulnerable atherosclerotic plaques.
- It offers insights into plaque composition and inflammatory activity.
- Further research is needed to establish its clinical utility compared to existing methods.
Abstract:
Atherosclerosis is one of the leading causes of morbidity and mortality in the world. Rupture of atherosclerotic plaques and thrombi formation are the primary mechanisms of myocardial infarction or cerebrovascular accident. Angiography is considered to represent the gold standard technique for imaging of the arterial lumen. However, in recent years it has been realized that the primary determinant of the atherosclerotic plaque stability is the composition of the plaque and other imaging modalities have been suggested. The purpose of this review is to briefly summarize the knowledge accumulated to present date regarding the potential role of fluodeoxyglucose imaging in the assessment of atherosclerosis and to compare this modality to additional available imaging approaches for the detection of vulnerable plaques.
More Related Videos
13:45A Method to Study the Correlation Between Local Collagen Structure and Mechanical Properties of Atherosclerotic Plaque Fibrous Tissue
Published on: November 11, 2022
09:43In vivo Near Infrared Fluorescence (NIRF) Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
Published on: August 4, 2011
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)